While the current approval focuses on the second-line setting, research is already moving into earlier stages of the ...

Instead of waiting until the disease has progressed, researchers have begun analyzing the effects of using immunotherapy before or after surgery in patients with early-stage lung cancer. The results, ...

Oncologists should consider neoadjuvant immunotherapy for patients with clinical stage III melanoma, which is a paradigm shift away from upfront surgery and adjuvant systemic therapy, according to a ...

A refrain I often hear from technology entrepreneurs to investors is that their product or solution is so innovative that it will cause a “paradigm shift” in the industry. Their assumption is that ...

Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: A Kansai Clinical Oncology Group study. This is an ASCO Meeting Abstract from the 2011 ASCO ...